Clinical Trials Listing

 

Breast Cancer Trials

  • Hoosier Oncology Group – COE01: Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer
  • Hoosier Oncology Group - COE03/BRE07-126:  A Phase II Study of Metastatic Breast Cancer
  • Eastern Cooperative Oncology Group (ECOG) – PACCT-1: TAILORx Trial
  • Eastern Cooperative Oncology Group (ECOG) – E5103: A Phase III Trial for Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
  • Novartis - CRAD001Y2301: A Phase III Trial of Post-Menopausal Women with Locally Advanced or Metastatic Breast Cancer
  • Wyeth – 3144A2-3003: A Phase III Trial for Locally Advanced or Metastatic Breast Cancer

Colorectal Cancer Trials / GI Cancer Trials

  • Hoosier Oncology Group – GI05-102:  A Phase I/Randomized Phase II Trial of Patients with Metastatic Colorectal Cancer

Lung Cancer Trials

  • Novartis – CASA404A2302: A Phase III Trial for Patients with Advanced or Metastatic Non Small Cell Lung Cancer
  • Hoosier Oncology Group – LUN06-113: A Phase II Trial for Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer
  • Merrimack - MM-121: A Phase I/II Trial for Patients with Non Small Cell Lung Cancer
  • Amgen 20080257 - A Phase Ib/II Study for Patients with Advanced Squamous Non Small Cell Lung Cancer

Myleodysplastic Trials

  • Amgen – 20060198: Trial for Subjects with Low or Intermediate -1 Risk Myelodysplastic Syndrome

Ovarian Cancer Trials

  • Endocyte – ECFV04: A Randomized Phase II Trial for Subjects with Platinum-Resistant Ovarian Cancer

Prostate Cancer Trials

  • Pfizer – A61181120: A Phase III Trial for Patients with Progressive Metastatic Hormone Refractory Prostate Cancer

Renal Cancer Trials

  • Eastern Cooperative Oncology Group (ECOG) – E2805: A Trial for Patients with Resected Renal Cell Carcinoma
  • Eastern Cooperative Oncology Group (ECOG) – E2804: A Phase II Trial for Patients with Advanced Renal Cell Carcinoma

Miscellaneous Trials

  • Amgen – 20060392 (STARS): Patients with Bone Metastases Secondary to Breast, Prostate or Lung Cancer, or Multiple Myeloma
  • Wyeth – 3144A1-2206:  A Phase I/II Trial for Subjects with Solid Tumors and ErbB-2 Positive Met or Locally Advanced Breast Cancer.
  • Purdue – Characterization of the Multiple Myeloma Cancer Stem Cells and its Niche-Bone Marrow Trial
  • Purdue - Identification of Genes, Proteins, or Metabolites as Biomarkers for Metastatic Breast Cancer
  • Endocyte – EC-0489-01:  A Phase I Trial for Subjects with Solid Tumors
  • OSI - OSI-906-202: A Phase I/II Study for Patients with Recurrent Epithelial Ovarian Cancer
  • Hoosier Oncology Group - BNK09-138: Biorepository Study for Patients With and Without Cancer